Valuation: EBOS Group Limited

Market Cap 3.58B 2.49B 2.23B 2.05B 1.86B 3.49B 236B 24.42B 9.82B 125B 9.36B 9.16B 395B P/E 2027 *
15.3x
P/E 2028 * 13.3x
Enterprise Value 4.59B 3.2B 2.86B 2.63B 2.38B 4.48B 303B 31.34B 12.61B 160B 12.01B 11.75B 507B EV / Sales 2027 *
0.33x
EV / Sales 2028 * 0.31x
Free-Float
90.8%
Yield 2027 *
5.44%
Yield 2028 * 6.01%
1 day-1.39%
1 week-1.39%
1 month-2.66%
3 months-12.77%
6 months-14.16%
Current year-35.26%
1 week 22.68
Extreme 22.68
22.68
1 month 19.66
Extreme 19.66
23
Current year 19.66
Extreme 19.66
46.64
1 year 19.66
Extreme 19.66
46.64
3 years 19.66
Extreme 19.66
47.23
5 years 19.66
Extreme 19.66
47.23
10 years 19.66
Extreme 19.66
47.23
Manager TitleAgeSince
Chief Executive Officer 51 01/07/2025
Director of Finance/CFO - 30/09/2024
Chief Tech/Sci/R&D Officer - 05/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 01/07/2019
Director/Board Member 60 01/07/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-1.39% - - 2.48B
-0.11%+10.18%+63.34%+142.88% 1,257B
-1.62%-0.05%+40.93%+77.16% 651B
-0.98%-0.26%+31.17%+99.64% 510B
-1.56%-1.39%+51.02%+64.18% 388B
-2.49%+2.89%+68.26%+40.66% 366B
-0.02%+3.15%+32.47%+55.33% 303B
-0.72%+7.05%+10.34%+32.79% 288B
-0.90%+3.74%+54.56%+73.02% 252B
-1.68%+5.53%+39.80%+106.17% 211B
Average -0.79%+4.59%+43.54%+76.87% 469.63B
Weighted average by Cap. -0.25%+5.30%+47.77%+91.67%

Financials

2027 *2028 *
Net sales 14.02B 9.77B 8.73B 8.02B 7.28B 13.68B 926B 95.71B 38.5B 488B 36.67B 35.89B 1,548B 14.64B 10.2B 9.12B 8.37B 7.6B 14.28B 967B 99.95B 40.21B 510B 38.3B 37.48B 1,617B
Net income 228M 159M 142M 130M 118M 222M 15.03B 1.55B 625M 7.93B 595M 583M 25.14B 263M 184M 164M 151M 137M 257M 17.39B 1.8B 723M 9.18B 689M 674M 29.08B
Net Debt 1.01B 707M 632M 580M 527M 989M 66.96B 6.92B 2.79B 35.34B 2.65B 2.6B 112B 976M 680M 608M 558M 507M 952M 64.42B 6.66B 2.68B 34B 2.55B 2.5B 108B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
17.28AUD
Average target price
23.19AUD
Spread / Average Target
+34.22%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited